Pulmotect, Inc.
www.pulmotect.comPulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body's innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi, and viral pathogens.
Read more
Pulmotect has developed PUL-042, an inhaled therapeutic which aims to boost the body's innate immune system resulting in highly-targeted lung protection against all major classes of pathogens including bacteria, fungi, and viral pathogens.
Read more
Country
State
Texas
City (Headquarters)
Houston
Industry
Employees
1-10
Founded
2007
Estimated Revenue
$5,000,000 to $10,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
President
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Member Board of Directors
Email ****** @****.comPhone (***) ****-****Member , Board of Directors
Email ****** @****.comPhone (***) ****-****
Technologies
(16)
Reach decision makers at Pulmotect, Inc.
Free credits every month!
Pulmotect, Inc. FAQ
Houston, United States
Pharmaceutical Manufacturing
